أعرض في EDS

Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting

التفاصيل البيبلوغرافية
العنوان: Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting
المؤلفون: Valentina Donati, Sara Galimberti, Stefano Sacchi, Stefania Bettelli, Tamar Tadmor, Pellegrino Musto, Aaron Polliack, Martina Quintini, Raffaella Marcheselli, Elisa Forti, Robel Papotti, Luigi Marcheselli, Antonino Maiorana, Samantha Pozzi, L. Flenghi, Arianna Di Napoli, Vittoria Lalinga, Giovanna Mansueto, M. Christina Cox
المصدر: Leukemia research. 104
سنة النشر: 2020
مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Poor prognosis, Vincristine, Cyclophosphamide, Lymphoma, cell of origin (COO), BCL2/MYC status, IPI, Diffuse Large B-cell Lymphoma (DLBCL), Adolescent, Cell of origin, Proto-Oncogene Proteins c-myc, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Doxorubicin, Female, Humans, Middle Aged, Prednisone, Retrospective Studies, Rituximab, Lymphoma, Large B-Cell, Diffuse, Proto-Oncogene Proteins c-bcl-2, Internal medicine, medicine, 80 and over, Large B-Cell, business.industry, Hematology, medicine.disease, Diffuse, business, Diffuse large B-cell lymphoma, medicine.drug
تدمد: 1873-5835
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::830a001437de0e21d4bfd530393fba56
https://pubmed.ncbi.nlm.nih.gov/33689920
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....830a001437de0e21d4bfd530393fba56
قاعدة البيانات: OpenAIRE
الوصف
تدمد:18735835